Related Experiment Videos
Lymphocyte subsets in renal carcinoma--a sequential study using monoclonal antibodies
British Journal of Urology
|April 1, 1984
Summary
Renal carcinoma significantly impacts immune function, causing a deficit in helper T cells. Nephrectomy restores these T cells, improving immune balance in most patients, but disease progression can reverse these effects.
Area of Science:
- Immunology
- Oncology
- Nephrology
Background:
- Renal carcinoma is associated with immune dysregulation.
- Understanding lymphocyte subset changes is crucial for assessing disease impact.
Purpose of the Study:
- To enumerate circulating lymphocyte subsets in renal carcinoma patients.
- To investigate the impact of disease progression and treatment on immune cell populations.
Main Methods:
- Monoclonal antibodies and flow cytometry were used to analyze lymphocyte subsets.
- Patient samples were analyzed at presentation and sequentially during treatment.
Main Results:
- Untreated patients showed a deficit in helper T cells (Leu-3a+) and abnormal helper/suppressor T cell ratios.
- Nephrectomy led to a significant increase in helper T cells and improved T cell ratios.
- Disease progression was associated with a loss of these immune improvements.
Conclusions:
- Renal carcinoma induces immunosuppression, characterized by T cell deficits.
- Nephrectomy can restore immune balance, but sustained improvement depends on disease control.
- Embolization prior to nephrectomy did not significantly alter outcomes compared to nephrectomy alone.